{{ siteCtrl.appService.consultant.DisplayName }} {{ siteCtrl.appService.consultant.DisplayName2 }}  
News 2018-06-12T16:14:25+00:00

BLOG

AloeVeritas Announces Preliminary Data from Ongoing Phase 1 Observational Study of AloeMD

AloeVeritas Announces Preliminary Data from Ongoing Phase 1 Observational Study of AloeMD (a drug-less pain disruptor) Showing Strong Evidence of Significant Results in Participants with Acute and Chronic Pain.

Read more

Alo­eVer­i­tas: Along with PainSmarts and the GPOSO, Announce Initiation of Phase I Observational Study Evaluating AloeMD

AloeVeritas today announced the call for consumer volunteers in a Phase I study of AloeMD, also known as an extracellular matrix protector and pain disruptor.

Read more

Alo­eVer­i­tas Announces the Launch of AloeMD

AloeVeritas Launched a new patented 100% natural arthritis and joint pain product that not only provides drug free and opioid free relief, but also boosts the body’s own innate intelligence to repair itself.

Read more

Alo­eVer­i­tas – A new shin­ing star in the net­work mar­ket­ing uni­verse

Following a successful launch in Europe where month-over-month growth exceeded 150%, AloeVeritas will soon bring a holistic plan for wellness to the United States.

Read more